Regulatory Expertise VPG Health specializes in patient-centered outcome assessments for regulatory submissions, offering end-to-end support from study design to dossiers and regulator meetings, which can be leveraged to position cross-domain COA services to pharma and device clients seeking faster approval pathways.

Clinical Outcomes Focus With a track record in de novo COA development and adapting existing measures to new contexts, VPG Health can upsell advanced psychometrics, construct definition, and context-of-use expansion to companies aiming to extend COA utility across multiple indications.

Cloud-Based Solutions Recent launch of HLMix on SSI Live indicates a capability and interest in cloud-based, scalable analytics platforms, offering a pathway to cross-sell software-as-a-service data analysis, remote collaboration, and real-time COA modeling for clients.

Strategic Acquisitions VPG’s history of expanding capabilities through acquisitions (e.g., SSI) demonstrates a growth trajectory and potential to target not only COA services but adjacent statistical software and data analytics tools to broaden client offerings.

Mid-market Target With 11-50 employees and annual revenue in the low to mid millions, VPG Health sits in a mid-market niche with sizable potential for upsell into larger pharma/biotech accounts that require comprehensive COA programs, regulatory documentation support, and integrated analytics.